Secure reversal of immune evasion from refractory NSCLC and highly contagious CoV-2 mutants by using 3D-engineered multifunctional biologics.

Authors:
Zhang Y; Li Q; Liu N; Hu J; Lin X and 4 more

Journal:
Bioeng Transl Med

Publication Year: 2023

DOI:
10.1002/btm2.10554

PMCID:
PMC10487317

PMID:
37693048

Journal Information

Full Title: Bioeng Transl Med

Abbreviation: Bioeng Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1: supporting information click here for additional data file."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare that they have no competing interests."

Evidence found in paper:

"FUNDING INFORMATION This investigation was supported by National High‐tech Research and Development Program (2014ZX09101041‐002) and National Natural Science Foundation (32200957) and China Postdoctoral Science Foundation (2020M673232) and Post‐Doctor Research Project, West China Hospital, Sichuan University (2020HXBH115)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025